Apellis Pharmaceuticals
APLS
HK$172.22
Share price
-8.77%
Change (1 day)
-63.15%
Change (1 year)
Categories
Earnings for Apellis Pharmaceuticals (APLS)
Earnings in 2024 (TTM): -HK$1.54 Billion
According to Apellis Pharmaceuticals's latest financial reports the company's current earnings are HK$0.78 Billion. , an increase over its 2023 earnings that were of -HK$4.1 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Apellis Pharmaceuticals from 2017 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -HK$1.54 Billion | -62.64% |
| 2023 | -HK$4.1 Billion | -19.19% |
| 2022 | -HK$5.07 Billion | -12.67% |
| 2021 | -HK$5.81 Billion | 117.47% |
| 2020 | -HK$2.67 Billion | 12.58% |
| 2019 | -HK$2.38 Billion | 139.78% |
| 2018 | -HK$0.99 Billion | 149.14% |
| 2017 | -HK$0.4 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -HK$1.12 Billion | -27.36% | 🇺🇸 USA |